Spotlight
Clinical Role
Clinical
Supplement Spotlight
CME/CE
Subscribe
How Often Do Patients with ASCVD Achieve Target LDL-C?
A panel of clinical pharmacists introduce themselves and discuss how LDL cholesterol target achievement compares with guideline goals for patients with ASCVD who are treated with maximally tolerated statin monotherapy.
Now Viewing
EP: 1.How Often Do Patients with ASCVD Achieve Target LDL-C?
EP: 2.Gaps Between Guidelines and Clinical Practice Patterns in ASCVD
EP: 3.Comparing the ACC/AHA and ESC/EAS Cholesterol Management Guidelines
EP: 4.Key Barriers in Implementing Guideline-Directed Cholesterol Treatment
EP: 5.Evaluating Non-Statin Lipid-Lowering Therapies in ASCVD
EP: 6.Clinical Efficacy of Non-Statin Treatment Options in ASCVD
EP: 7.Non-Statin Therapies: Cost Effectiveness and Clinical Evidence Gaps
EP: 8.Persistence and Discontinuation Rates for Non-Statin Therapies in ASCVD
EP: 9.The Role of Pharmacists in Treating Very High-Risk ASCVD
EP: 10.Valuable Metrics and Improving Adherence in Patients With ASCVD
EP: 11.Successful Collaborative Care Strategies for Pharmacists
Recent Videos
Related Content
